About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study for Prevention of Cervical Cancer in Spain | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07113379

Study for Prevention of Cervical Cancer in Spain

The REVIVE study aims to analyze the current status of Human Papillomavirus (HPV) vaccination programs and cervical cancer screening strategies in Spain. Its objective is to gain a comprehensive under...

Lead sponsor: Clinica Universidad de Navarra, Universidad de Navarra•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Female patients diagnosed with squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix.
•Diagnosis established between 2019 and 2024.

Exclusion Criteria

•Patients aged below 18 years at diagnosis.
•Diagnosis of other cervical cancer histologies (e.g., neuroendocrine tumors, sarcoma, lymphoma).
•Patents with significant cognitive impairment precluding informed consent for data utilization, where applicable.
•Patients with incomplete medical records relevant to the study variables.

Related studies

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

NCT07550010 · Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia Grade 2 (CIN2), and more

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

NCT07290972 · Cervical Cancer Screening, Gynecologic Cancers, and more

Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine

NCT07275333 · Cervical Cancer, Cervical Cancer Screening, and more

Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon

NCT07181278 · Cervical Cancer Screening, HIV

Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women

NCT05390567 · Cervical Cancer Screening Methods

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 8, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment200

Start dateOct 2025

Last updatedAug 8, 2025

Condition

Cervical Cancer Screening HPV Vaccination

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 8, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions